These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1216 related articles for article (PubMed ID: 26095523)
1. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. El-Hattab AW; Adesina AM; Jones J; Scaglia F Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523 [TBL] [Abstract][Full Text] [Related]
2. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome. El-Hattab AW; Emrick LT; Chanprasert S; Craigen WJ; Scaglia F Int J Biochem Cell Biol; 2014 Mar; 48():85-91. PubMed ID: 24412347 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique. El-Hattab AW; Jahoor F J Nutr; 2017 Jul; 147(7):1251-1257. PubMed ID: 28515163 [TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of MELAS and L-arginine effects. Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974 [TBL] [Abstract][Full Text] [Related]
5. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. El-Hattab AW; Emrick LT; Craigen WJ; Scaglia F Mol Genet Metab; 2012 Nov; 107(3):247-52. PubMed ID: 22819233 [TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Fan HC; Lee HF; Yue CT; Chi CS Life (Basel); 2021 Oct; 11(11):. PubMed ID: 34832987 [TBL] [Abstract][Full Text] [Related]
7. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238 [TBL] [Abstract][Full Text] [Related]
8. Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation. El-Hattab AW; Emrick LT; Hsu JW; Chanprasert S; Almannai M; Craigen WJ; Jahoor F; Scaglia F Mol Genet Metab; 2016 Apr; 117(4):407-12. PubMed ID: 26851065 [TBL] [Abstract][Full Text] [Related]
9. Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report. Lahiri D; Sawale VM; Banerjee S; Dubey S; Roy BK; Das SK J Med Case Rep; 2019 Mar; 13(1):63. PubMed ID: 30837005 [TBL] [Abstract][Full Text] [Related]
10. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Santa KM Pharmacotherapy; 2010 Nov; 30(11):1179-96. PubMed ID: 20973690 [TBL] [Abstract][Full Text] [Related]
11. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs. Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977 [TBL] [Abstract][Full Text] [Related]
12. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options. Scaglia F; Northrop JL CNS Drugs; 2006; 20(6):443-64. PubMed ID: 16734497 [TBL] [Abstract][Full Text] [Related]
13. Acute myocardial infarction in a patient with MELAS syndrome: a possible link? Cosma J; Russo A; Schino S; Belli M; Mango R; Chiricolo G; Martuscelli E; Mariano EG Minerva Cardiol Angiol; 2023 Aug; 71(4):374-380. PubMed ID: 35767235 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Sproule DM; Kaufmann P Ann N Y Acad Sci; 2008 Oct; 1142():133-58. PubMed ID: 18990125 [TBL] [Abstract][Full Text] [Related]
15. Ischemic optic neuropathy as first presentation in patient with m.3243 A > G MELAS classic mutation. Scarcella S; Dell'Arti L; Gagliardi D; Magri F; Govoni A; Velardo D; Mainetti C; Minorini V; Ronchi D; Piga D; Comi GP; Corti S; Meneri M BMC Neurol; 2023 Apr; 23(1):165. PubMed ID: 37095452 [TBL] [Abstract][Full Text] [Related]
16. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600 [TBL] [Abstract][Full Text] [Related]
17. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Koga Y; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T Ann N Y Acad Sci; 2010 Jul; 1201():104-10. PubMed ID: 20649546 [TBL] [Abstract][Full Text] [Related]
18. Arginine and citrulline for the treatment of MELAS syndrome. El-Hattab AW; Almannai M; Scaglia F J Inborn Errors Metab Screen; 2017 Jan; 5():. PubMed ID: 28736735 [TBL] [Abstract][Full Text] [Related]
19. MELAS phenotype associated with m.3302A>G mutation in mitochondrial tRNA(Leu(UUR)) gene. Goto M; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Nishino I; Goto Y Brain Dev; 2014 Feb; 36(2):180-2. PubMed ID: 23582502 [TBL] [Abstract][Full Text] [Related]